ATI RN
Cardiovascular System Exam Questions
1. What is the term that describes the inability of cardiac cells to respond to a new stimulus while they are still in contraction from a previous stimulus?
- A. Refractoriness
- B. Excitability
- C. Contractility
- D. Automaticity
Correct answer: A
Rationale: Refractoriness is the correct term to describe the inability of cardiac cells to respond to a new stimulus while they are still in contraction from a previous stimulus. This period is essential for the heart to complete its contraction and relaxation phases without interference. Excitability refers to the ability of cells to respond to stimuli, not the inability to respond. Contractility is the force of cardiac muscle contraction, and automaticity is the ability of cardiac cells to generate electrical impulses spontaneously, which are not relevant to the described scenario.
2. The client on a beta blocker has a blood pressure of 88/58 mm Hg. What is the nurse’s priority action?
- A. Hold the beta blocker and notify the healthcare provider.
- B. Administer the beta blocker as ordered.
- C. Increase the dose of the beta blocker.
- D. Continue to monitor the client and reassess in 30 minutes.
Correct answer: A
Rationale: The correct action for the nurse to take when a client on a beta blocker presents with a blood pressure of 88/58 mm Hg is to hold the beta blocker and notify the healthcare provider. Beta blockers can further decrease blood pressure, which is already low in this case. Administering the beta blocker as ordered (Choice B) would exacerbate the hypotension. Increasing the dose of the beta blocker (Choice C) would be inappropriate and unsafe given the low blood pressure. Continuing to monitor the client and reassessing in 30 minutes (Choice D) could lead to a delay in necessary intervention. Therefore, the priority is to hold the medication and seek guidance from the healthcare provider.
3. The client on spironolactone (Aldactone) has a potassium level of 5.6 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.6 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels. Therefore, the priority action is to withhold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further management. Option B is incorrect because administering potassium supplements would worsen the hyperkalemia. Option C is incorrect as continuing spironolactone can lead to a further increase in potassium levels. Option D is incorrect as increasing the dose of spironolactone would be inappropriate in the presence of elevated potassium levels.
4. The nurse is administering a calcium channel blocker. What is the primary effect of this medication on the cardiovascular system?
- A. Decreases heart rate
- B. Increases heart rate
- C. Increases blood pressure
- D. Decreases blood pressure
Correct answer: D
Rationale: The correct answer is D: Decreases blood pressure. Calcium channel blockers primarily work by relaxing the blood vessels, leading to a decrease in blood pressure. Choice A, 'Decreases heart rate,' is incorrect because calcium channel blockers do not significantly affect heart rate. Choice B, 'Increases heart rate,' is incorrect as calcium channel blockers do not have a primary effect of increasing heart rate. Choice C, 'Increases blood pressure,' is incorrect as the primary effect of calcium channel blockers is to decrease blood pressure by vasodilation.
5. Which disease is characterized by the damage to the alveoli in the lungs, leading to breathlessness?
- A. Emphysema
- B. Pulmonary fibrosis
- C. Lung cancer
- D. Lung abscess
Correct answer: A
Rationale: The correct answer is A, Emphysema. Emphysema is a lung condition characterized by the damage to the air sacs (alveoli) in the lungs, which results in breathlessness and reduced lung function. Pulmonary fibrosis (B) is a condition where lung tissue becomes damaged and scarred, leading to stiffness in the lungs. Lung cancer (C) is a malignancy affecting the lungs, which can cause various symptoms depending on the stage. Lung abscess (D) is a localized collection of pus within the lung tissue, typically caused by a bacterial infection.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access